Report cover image

U.S. Point of Care Lipid Test Market Size, Share, Trends, Industry Analysis Report By Product (Instruments, Consumables), By Application, By Disease Indication, By End Use– Market Forecast, 2025–2034

Publisher Polaris Market Research & Consulting LLP
Published Jul 01, 2025
Length 129 Pages
SKU # PLRS20324598

Description

The U.S. point of care (POC) lipid test market size is expected to reach USD 553.25 million by 2034, according to a new study by Polaris Market Research. The report “U.S. Point of Care Lipid Test Market Size, Share, Trends, Industry Analysis Report By Product (Instruments, Consumables), By Application, By Disease Indication, By End Use– Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

A point of care (POC) lipid test is a diagnostic tool used to measure lipid levels such as total cholesterol, HDL, LDL, and triglycerides, directly at the site of patient care. It provides rapid results from a small blood sample, often within minutes, without needing a central laboratory.

The U.S. healthcare system is increasingly focusing on preventive care to reduce long-term costs and improve patient outcomes. Regular cholesterol screening is a key part of this approach, especially for at-risk groups such as the elderly or those with diabetes. Point of care lipid tests support this preventive model by offering immediate results during routine visits. This eliminates the need for lab processing and encourages more frequent testing. Preventive care is propelling the U.S. POC lipid test market with wellness programs, employer-sponsored health checks, and government-supported initiatives promoting early detection.

Innovation in diagnostic services and technology is rapidly transforming point of care lipid testing in the U.S. Modern lipid testing devices offer better accuracy, faster results, and user-friendly interfaces, making them ideal for various healthcare settings. Bluetooth-enabled meters, smartphone integration, and compact portable analyzers have increased the utility and convenience of POC lipid tests. Companies such as Abbott and Roche are continuously launching improved products tailored to the U.S. These advancements attract both healthcare providers and patients, further accelerating adoption across clinical and nonclinical environments, thereby driving the POC lipid test market growth.

U.S. Point of Care Lipid Test Market Report Highlights

In 2024, the consumables segment dominated with the largest share due to its recurring demand and widespread use.

The hypertriglyceridemia segment is expected to experience significant growth during the forecast period, driven by factors such as obesity, high sugar intake, sedentary lifestyles, and poor diet.

A few key market players are Abbott Laboratories; Callegari Srl; F. Hoffmann-La Roche Ltd.; Menarini Group; MiCoBio; Nova Biomedical; SD Biosensor, Inc.; Sinocare Inc.; and VivaChek Biotech (Hangzhou) Co., Ltd.

Polaris Market Research has segmented the U.S. point of care lipid test market report on the basis of product, application, disease indication, end use, and region:

By Product (Revenue – USD Million, 2020–2034)

Instruments

Consumables

By Application (Revenue – USD Million, 2020–2034)

Hyperlipidemia

Hypertriglyceridemia

Tangier Disease

Hyperlipoproteinemia

Familial Hypercholesterolemia

Others

By Disease Indication (Revenue – USD Million, 2020–2034)

Lipid and Lipoprotein Disorders

Atherosclerosis

Liver and Renal Diseases

Diabetes Mellitus

Others

By End Use (Revenue – USD Million, 2020–2034)

Hospitals

Clinics

Research and Diagnostic Laboratories

Others

Table of Contents

129 Pages
1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. U.S. Point of Care Lipid Test Market Insights
4.1. Point of Care Lipid Test Market – Market Snapshot
4.2. Point of Care Lipid Test Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Rising Incidence of Obesity and Diabetes
4.2.1.2. Rising Prevalence of Cardiovascular Diseases
4.2.2. Restraints and Challenges
4.2.2.1. High Initial Investment
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Point of Care Lipid Test Market Trends
4.6. Value Chain Analysis
5. U.S. Point of Care Lipid Test Market, by Product
5.1. Key Findings
5.2. Introduction
5.2.1. U.S. Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
5.3. Instruments
5.3.1. U.S. Point of Care Lipid Test Market, by Instruments, 2020–2034 (USD million)
5.4. Consumables
5.4.1. U.S. Point of Care Lipid Test Market, by Consumables 2020–2034 (USD million)
6. U.S. Point of Care Lipid Test Market, by Application
6.1. Key Findings
6.2. Introduction
6.2.1. U.S. Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
6.3. Hyperlipidemia
6.3.1. U.S. Point of Care Lipid Test Market, by Hyperlipidemia 2020–2034 (USD million)
6.4. Hypertriglyceridemia
6.4.1. U.S. Point of Care Lipid Test Market, by Hypertriglyceridemia 2020–2034 (USD million)
6.5. Tangier Disease
6.5.1. U.S. Point of Care Lipid Test Market, by Tangier Disease, 2020–2034 (USD million)
6.6. Hyperlipoproteinemia
6.6.1. U.S. Point of Care Lipid Test Market, by Hyperlipoproteinemia, , 2020–2034 (USD million)
6.7. Familial Hypercholesterolemia
6.7.1. U.S. Point of Care Lipid Test Market, by Familial Hypercholesterolemia, 2020–2034 (USD million)
6.8. Others
6.8.1. U.S. Point of Care Lipid Test Market, by Others, 2020–2034 (USD million)
7. U.S. Point of Care Lipid Test Market, by Disease Indication
7.1. Key Findings
7.2. Introduction
7.2.1. U.S. Point of Care Lipid Test Market, by Medical Biotechnology, 2020-2034 (USD million)
7.3. Lipid and Lipoprotein Disorders
7.3.1. U.S. Point of Care Lipid Test Market, by Lipid and Lipoprotein Disorders, 2020–2034 (USD million)
7.4. Atherosclerosis
7.4.1. U.S. Point of Care Lipid Test Market, by Atherosclerosis, 2020–2034 (USD million)
7.5. Liver and Renal Diseases
7.5.1. U.S. Point of Care Lipid Test Market, by Liver and Renal Diseases, by Region, 2020–2034 (USD million)
7.6. Diabetes Mellitus
7.6.1. U.S. Point of Care Lipid Test Market, by Diabetes Mellitus, 2020–2034 (USD million)
7.7. Others
7.7.1. U.S. Point of Care Lipid Test Market, by Others, 2020–2034 (USD million)
8. U.S. Point of Care Lipid Test Market, by End Use
8.1. Key Findings
8.2. Introduction
8.2.1. U.S. Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
8.3. Hospitals
8.3.1. U.S. Point of Care Lipid Test Market, by Hospitals, 2020–2034 (USD million)
8.4. Clinics
8.4.1. U.S. Point of Care Lipid Test Market, by Clinics, 2020–2034 (USD million)
8.5. Research and Diagnostic Laboratories
8.5.1. U.S. Point of Care Lipid Test Market, by Research and Diagnostic Laboratories, 2020–2034 (USD million)
8.6. Others
8.6.1. U.S. Point of Care Lipid Test Market, by Others, 2020–2034 (USD million)
9. Competitive Landscape
9.1. Expansion and Acquisition Analysis
9.1.1. Expansion
9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
10.1. Abbott Laboratories
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Product Benchmarking
10.1.4. Recent Development
10.2. Callegari Srl
10.2.1. Company Overview
10.2.2. Financial Performance
10.2.3. Product Benchmarking
10.2.4. Recent Development
10.3. F. Hoffmann-La Roche Ltd.
10.3.1. Company Overview
10.3.2. Financial Performance
10.3.3. Product Benchmarking
10.3.4. Recent Development
10.4. Menarini Group
10.4.1. Company Overview
10.4.2. Financial Performance
10.4.3. Product Benchmarking
10.4.4. Recent Development
10.5. MiCoBio
10.5.1. Company Overview
10.5.2. Financial Performance
10.5.3. Product Benchmarking
10.5.4. Recent Development
10.6. Nova Biomedical
10.6.1. Company Overview
10.6.2. Financial Performance
10.6.3. Product Benchmarking
10.6.4. Recent Development
10.7. SD Biosensor, Inc.
10.7.1. Company Overview
10.7.2. Financial Performance
10.7.3. Product Benchmarking
10.7.4. Recent Development
10.8. Sinocare Inc.
10.8.1. Company Overview
10.8.2. Financial Performance
10.8.3. Product Benchmarking
10.8.4. Recent Development
10.9. VivaChek Biotech (Hangzhou) Co., Ltd.
10.9.1. Company Overview
10.9.2. Financial Performance
10.9.3. Product Benchmarking
10.9.4. Recent Development

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us